AI assistant
SMS Pharmaceuticals Ltd Major Shareholding Notification 2023
62302_rns_2023-05-19_88c5cf41-6de9-4a44-9b29-1f3041bd4e6a.pdf
Major Shareholding Notification
Open in viewerOpens in your device viewer
Registered & Corporate Office : Plot No. 72, H. No. 8-2-334/3 & 4, Road No. 5, Opp. SBI Executive Enclave, Banjara Hills, Hyderabad - 500 034, Telangana, INDIA. Tel: +91-40-2525 9999, Fax: +91-40-2525 9889 CIN: L24239TG1987PLC008066 Email: [email protected], www.smspharma.com
Date: 05th April, 2023
To, The Manager, Corporate Filings Department, BSE Limited, Phiroze Jeejeebhoy Towers, Dalal Street. Mumbai-400 001
The Manager, Listing Compliance Department, National Stock Exchange of India Ltd. Exchange Plaza, Plot no. C/1, G Block, Bandra-Kurla Complex, Bandra (E), Mumbai - 400 051.
Symbol: SMSPHARMA
Dear Sir/Madam,
Security Code: 532815
SUB: DISCLOSURE UNDER REGULATION 31(4) OF SEBI (SUBSTANTIAL ACQUISITION OF SHARES AND TAKEOVERS) REGULATIONS, 2011
Pursuant to the provisions of Regulation 31(4) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, we hereby confirm that no members of Promoter and Promoter Group including person acting in concert have made any encumbrance of shares, directly or indirectly during the financial year ended March 31, 2023.
Current equity shares already in encumbrance are as given below:
| Sl. No. | Name of the Promoter | Equity shareheld | Equity sharespledged |
|---|---|---|---|
| 1. | Mr. Vamsi Krishna Potluri | 1,33,28,370 | 20,30,590 (15.24%) |
| 2. | M/s. Potluri Infra Projects LLP | 73,46,420 | 38,00,000 (51.73%) |
Kindly take the disclosure in your records.
Thanking You
Yours Truly
Ramesh Babu Potluri On behalf of Promoter & Promoter Group SMS Pharmaceuticals Limited